Written by
in
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.
BERLIN — For years, scientists have held out hope that tests that look for the molecular fingerprints of a cancer’s…
